These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6753393)

  • 41. [Treatment of essential hypertension with baronorm. Results of an experimentation on 35 cases].
    Menechet F; Fontanille P
    Bord Med; 1972 Apr; 5(7):851-4. PubMed ID: 5055353
    [No Abstract]   [Full Text] [Related]  

  • 42. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
    Pascal N; Eggert R
    Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Controlled studies on the therapeutic efficacy of a new antihypertensive agent: Aldatense].
    Barbara L; Melchionda N
    Minerva Cardioangiol; 1972 Sep; 20(9):516-25. PubMed ID: 5071472
    [No Abstract]   [Full Text] [Related]  

  • 44. [Beta-blocker monotherapy in hypertension. A clinical study].
    Schrey A; Müller G; Schmidt-Voigt J; Grund R; Forst HT
    Med Welt; 1981 Apr; 32(14):468-72. PubMed ID: 7219160
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 46. [Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
    Grajek S; Szymczyńska A; Urbański K; Lehman Z; Kozłowska F; Paradowski S; Gracz M
    Kardiol Pol; 1986; 29(7):440-53. PubMed ID: 2879953
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness of Viskaldix in patients with primary hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1983 Nov; 38(45):1399-401. PubMed ID: 6374634
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical trial of baronorm in the treatment of hypertension].
    Ben-Ismail M; Girardet JP
    Tunis Med; 1972; 50(2):145-8. PubMed ID: 4661605
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hypotensive effect of tobanum in hypertension].
    Shliakhto EV; Savushkin SN; Bondarenko BB
    Sov Med; 1989; (10):65-7. PubMed ID: 2694384
    [No Abstract]   [Full Text] [Related]  

  • 50. [The treatment of hypertension with bupranolol. Results of a daily dosage administration schedule].
    Grund R; Forst HT
    ZFA (Stuttgart); 1981 Mar; 57(8):621-7. PubMed ID: 7222996
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined treatment of hypertension patients].
    Panikarskiĭ VG
    Vrach Delo; 1984 Oct; (10):77-9. PubMed ID: 6151317
    [No Abstract]   [Full Text] [Related]  

  • 53. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC; Ortíz Feijoo J; Otero Cagide F
    Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract]   [Full Text] [Related]  

  • 54. [Results of a field study with dehydro sanol tri from a statistical point of view].
    Haase W
    Med Welt; 1978 Jan; 29(4):150-6. PubMed ID: 345041
    [No Abstract]   [Full Text] [Related]  

  • 55. [Triamterene (2,4,7-triamino-6-phenylpteridine) in the treatment of essential hypertension].
    Pippig L; Schmitt W; Buck R
    Arzneimittelforschung; 1965 Mar; 15(3):285-9. PubMed ID: 5897220
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclothiazide and atenolol once daily in essential hypertension.
    Pitkäjärvi T
    Ann Clin Res; 1979 Feb; 11(1):1-8. PubMed ID: 378090
    [No Abstract]   [Full Text] [Related]  

  • 57. [A pharmacokinetic study of korinfar-retard in monotherapy and in combination with cordanum and triampur in patients with arterial hypertension].
    Kukes VG; Ignat'ev VI; Kurapov AP; Pavlov SS; Rumiantsev AS; Chil'tsov VV
    Eksp Klin Farmakol; 1994; 57(6):50-2. PubMed ID: 7756964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
    Jaffé G; Grimshaw JJ; Vallé-Jones JC; Warnock JM
    Practitioner; 1982 Feb; 226(1364):355-8. PubMed ID: 7088834
    [No Abstract]   [Full Text] [Related]  

  • 59. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 60. [Dose-response study of betaxolol in arterial hypertension].
    Pathe M; Steimer C; Cazor JL; Schwartz J
    Therapie; 1983; 38(2):143-8. PubMed ID: 6356451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.